Find Paper, Faster
Example:10.1021/acsami.1c06204 or Chem. Rev., 2007, 107, 2411-2502
Carbazate-modified cross-linked dextran microparticles suppress the progression of osteoarthritis by ROS scavenging
Biomaterials Science  (IF6.843),  Pub Date : 2021-07-13, DOI: 10.1039/d1bm00743b
Yanfeng Ding, Zhimin Li, Wenwen Hu, Xianjing Feng, Ying Chen, Guohua Yan, Yonglin Wang, Bo Zhu, Wei Yao, Li Zheng, Maolin He, Ming Gao, Jinmin Zhao

A series of modified polysaccharide microparticles have been fabricated and their potential application for scavenging reactive oxygen species (ROS) and their derivatives to achieve osteoarthritis (OA) treatment has been explored. These microparticles were cross-linked dextran (Sephadex) with different carbazate substitution ratios determined by the TNBS assay and elemental analysis. It has been demonstrated that they could effectively scavenge carbonylated proteins and ROS including hydroxyl radicals (˙OH), superoxide anions (˙O2) and H2O2 and their derivatives with high efficiency, improve the viability of H2O2-treated chondrocytes by reducing their ROS levels, as well as lower their inflammatory factors. The above ability of antioxidation and inflammation resistance improved with the increase of carbazate substitution ratio. Significantly, this work provided the proof that modified Sephadex successfully alleviated the deterioration of cartilage and the progression of OA in vivo. The proposed microparticles showed a very promising capability for reducing ROS levels and further treating OA.